Biggest News Aggregation in the World
📰 Planegg News

Planegg News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Planegg. Real-time updates on events, politics, business and more.

Ad hoc: Arkadius Pichota and Lukas Gilgen appointed to Management Board of MorphoSys AG replacing th

MorphoSys AG / Key word(s): PersonnelAd hoc: Arkadius Pichota and Lukas Gilgen appointed to Management Board of MorphoSys AG replacing the current CEO and CFO06-Jun-2024 / 22:19 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service...
United States Lucinda Crabtree Krisja Vermeylen Jean Paul Kress Andrew Cheng Silke Mainka

EQS-Adhoc: Ad hoc: Arkadius Pichota and Lukas Gilgen appointed to Management Board of MorphoSys AG replacing the current CEO and CFO - adhoc - Börsennachrichten

EQSAdhoc MorphoSys AG Key word Personnel Ad hoc Arkadius Pichota and Lukas Gilgen appointed to Management Board of MorphoSys AG replacing the current CEO and CFO 06Jun2024 2219 CETCEST Disclosure of
United States Lucinda Crabtree Julia Neugebauer Michael Brosnan Jean Paul Kress Andrew Cheng

EQS-Adhoc: Ad hoc: Arkadius Pichota and Lukas Gilgen appointed to Management Board of MorphoSys AG replacing the current CEO and CFO - adhoc - Börsennachrichten

EQSAdhoc MorphoSys AG Key word Personnel Ad hoc Arkadius Pichota and Lukas Gilgen appointed to Management Board of MorphoSys AG replacing the current CEO and CFO 06Jun2024 2219 CETCEST Disclosure of
United States Arkadius Pichota Lukas Gilgen Krisja Vermeylen George Golumbeski Julia Neugebauer

MorphoSys AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

EQS Voting Rights Announcement: MorphoSys AG MorphoSys AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of...
United States Morgan Stanley Capital Services Notification Of Major Holdings Morgan Stanley Domestic Holdings Morgan Stanley Morgan Stanley International

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

MorphoSys AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

EQS Voting Rights Announcement: MorphoSys AG MorphoSys AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of...
United Kingdom Fund Management Switzerland Americas Inc Ubs Ag Asset Management United Kingdom Financial Services Inc

MorphoSys AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

EQS Voting Rights Announcement: MorphoSys AG MorphoSys AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of...
United States Morgan Stanley Domestic Holdings Morgan Stanley International Holdings Inc Morgan Stanley Capital Management Morgan Stanley International Dealer Services Corp

MorphoSys AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

EQS Voting Rights Announcement: MorphoSys AG MorphoSys AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of...
United States Folio Financial Inc Goldman Sachs International Bank Goldman Sachs Co Goldman Sachs Bank Europe Goldman Sachs Group United Kingdom

Analyzing Graybug Vision (NASDAQ:GRAY) and MorphoSys (NASDAQ:MOR)

MorphoSys (NASDAQ:MOR – Get Free Report) and Graybug Vision (NASDAQ:GRAY – Get Free Report) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, profitability, risk, institutional ownership, earnings, dividends and analyst recommendations. Valuation & Earnings This table compares MorphoSys and Graybug […]
Redwood City United States Mereo Biopharma Incyte Corporation Human Immunology Biosciences Inc Xencor Inc

MorphoSys AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

EQS Voting Rights Announcement: MorphoSys AG MorphoSys AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of...
United Kingdom Fund Management Luxembourg Asset Management Holding Ltd Distribution Services Asset Management Americas Asset Management United Kingdom

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science